In the liver, these effects extend further: Reduced liver fat through mobilization of lipid stores Anti-inflammatory action that mitigates hepatocellular injury Fibrosis regression in patients with established scarring Cancer prevention potential, as chronic inflammation and fibrosis are major drivers of hepatocellular carcinoma This multifaceted benefit profile positions GLP-1s not merely as metabolic drugs, but as direct modulators of liver disease biology
These drugs mimic natural gut hormones to slow digestion, reduce appetite, and improve blood sugar control
Jarosz M, Olbert M, Wyszogrodzka G, Myniec K, Librowski T
Practical Nutrition Strategies to Reduce Tirzepatide Side Effects Eating smaller, more frequent meals is the single most effective dietary change during tirzepatide therapy
In our cohort, the majority of patients exhibited active IIH, especially in the UCWM group with significantly shorter disease duration, with slightly higher yet not significant change in the pRNFL thickness in this group
Weeks 13-24: Peak Results Phase The peak results phase sees continued fat loss at slightly reduced rates as the body approaches a new homeostatic set point